Federal Circuit Upholds Duty-Free Treatment for Pharmaceutical Ingredient
The Court of Appeals for the Federal Circuit in an April 26 opinion upheld a Court of International Trade ruling that gave duty-free treatment to darunavir ethanolate, the active ingredient in a HIV medication from drugmaker Janssen.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Finding that the ingredient is in fact darunavir by another name, and therefore is included in Table 1 of the Pharmaceutical Appendix, the trade court ruled against the government's arguments that darunavir ethanolate has a different Chemical Abstracts Service (CAS) number, and is not a derivative listed in Table 2.